| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| RAB4B-EGLN2 |
|
RAB4B-EGLN2 readthrough (NMD candidate)
|
|
|
0.641 |
0.654 |
| AIS1 |
|
autoimmune susceptibility 1
|
|
|
0.861 |
0.115 |
| AITD1 |
|
Autoimmune thyroid disease, susceptibility to, 1
|
|
|
0.861 |
0.115 |
| SLC26A4 |
O43511
|
solute carrier family 26 member 4
|
Transporter
|
9.0E-22 |
0.507 |
0.885 |
| AIRE |
O43918
|
autoimmune regulator
|
|
4.0E-12 |
0.516 |
0.808 |
| FLNB |
O75369
|
filamin B
|
|
6.1E-10 |
0.458 |
0.923 |
| GNAS |
O95467 P63092 P84996 Q5JWF2
|
GNAS complex locus
|
Enzyme modulator
|
0.68 |
0.420 |
0.885 |
| TGFB1 |
P01137
|
transforming growth factor beta 1
|
Signaling
|
3.7E-02 |
0.287 |
0.962 |
| NPPA |
P01160
|
natriuretic peptide A
|
|
5.5E-04 |
0.505 |
0.769 |
| TG |
P01266
|
thyroglobulin
|
Enzyme modulator
|
2.9E-59 |
0.480 |
0.808 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
| HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
| CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
| HLA-DPB1 |
P04440
|
major histocompatibility complex, class II, DP beta 1
|
Immune response
|
5.3E-10 |
0.453 |
0.923 |
| IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
| IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
| CSN2 |
P05814
|
casein beta
|
Storage
|
7.2E-06 |
0.641 |
0.538 |